Literature DB >> 21872430

The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted.

Cristina Iobagiu1, Anna Magyar, Leonor Nogueira, Martin Cornillet, Mireille Sebbag, Jacques Arnaud, Ferenc Hudecz, Guy Serre.   

Abstract

The major targets of the disease-specific autoantibodies to citrullinated proteins (ACPA) in synovium of rheumatoid arthritis (RA) patients are borne by the citrullinated α- and β-chains of fibrin. We demonstrated that ACPA target a limited set of citrullinated fibrin peptides and particularly four multicitrullinated peptides which present the major epitopes. In this study, we established the clear immunodominance of the peptides α36-50Cit(38,42) and β60-74Cit(60,72,74) which were recognised by 51/81 (63%) and 61/81 (75%) of ACPA-positive patients, respectively, more than 90% recognising one, the other or both peptides. We also identified the citrullyl residues αCit(42), βCit(72) and βCit(74) as essential for antigenicity, and at a lesser degree αCit(38). Then, we assayed on overlapping 7-mer peptides encompassing the sequences of the two peptides, 3 series of sera recognising either α36-50Cit(38,42) or β60-74Cit(60,72,74) or both peptides. In each series, the reactivity profiles of the sera, largely superimposable, allowed identification of the two 4/5-mer overlapping epitopes (α: VECit(42)HQ and α': Cit(38)VVE), and the single 5-mer epitope (β: GYCit(72)ACit(74)), all located to a flexible globular domain of fibrin on a topological 3D model. In conclusion, we demonstrated that only 3 immunodominant epitopes are targeted by ACPA on citrullinated fibrin stressing their actual oligoclonality. However, the reactivity to the 3 epitopes distinguishes three subgroups of patients. The closely restricted antigen specificity suggests that the autoimmune reaction to citrullinated fibrin is antigen-driven. The accessibility of the epitopes reinforces the hypothesis of a pathogenic role for ACPA via immune complexe formation in the synovial tissue. 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872430     DOI: 10.1016/j.jaut.2011.07.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  16 in total

Review 1.  The therapeutic potential of epigenetics in autoimmune diseases.

Authors:  Maria De Santis; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

Review 2.  Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms.

Authors:  Sylviane Muller; Marko Radic
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

3.  Meta-analysis: diagnostic accuracy of the citrullinated peptides derived from fibrinogen and vimentin in rheumatoid arthritis.

Authors:  Xue Li; Zhenni Wang; Han Yi; Jun Xie; Naishuo Zhu
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

Review 4.  Autoimmunity in 2011.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

5.  In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin.

Authors:  M Cornillet; E Verrouil; A Cantagrel; G Serre; L Nogueira
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

6.  Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.

Authors:  J D Goules; A V Goules; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

7.  Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.

Authors:  Kendra A Young; Kevin D Deane; Lezlie A Derber; Jan M Hughes-Austin; Catriona A Wagner; Jeremy Sokolove; Michael H Weisman; Jane H Buckner; Ted R Mikuls; James R O'Dell; Richard M Keating; Peter K Gregersen; William H Robinson; V Michael Holers; Jill M Norris
Journal:  Arthritis Rheum       Date:  2013-08

8.  Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.

Authors:  Monika Hansson; Linda Mathsson; Thomas Schlederer; Lena Israelsson; Per Matsson; Leonor Nogueira; Per-Johan Jakobsson; Karin Lundberg; Vivianne Malmström; Guy Serre; Rikard Holmdahl; Mats Nystrand; Lars Klareskog; Johan Rönnelid
Journal:  Arthritis Res Ther       Date:  2012-10-01       Impact factor: 5.156

9.  In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope.

Authors:  Guillaume Larid; Mikael Pancarte; Géraldine Offer; Cyril Clavel; Marielle Martin; Vincent Pradel; Isabelle Auger; Pierre Lafforgue; Jean Roudier; Guy Serre; Nathalie Balandraud
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

10.  Are antibodies to fine specificities of citrullinated peptides/proteins useful for stratification of rheumatoid arthritis patients?

Authors:  Leonor Nogueira; Emilie Parra; Margaux Larrieu; Evelyne Verrouil; Martin Cornillet
Journal:  Clin Transl Immunology       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.